To validate DTYMK function in tumor cells, we examined DTYMK expression in tumor cell lines of various origins (lung cancer including 95C, 95D, A549, and H1299; pancreatic cancer MIA PaCa-2; liver cancer HepG2) (Figure 14A). Here, DTYMK is linked to pancreatic neoplasm.